CRVL Form 4 — Alan Hoops Sells 2,000 Shares and Receives 1,500 Options
Rhea-AI Filing Summary
Alan Hoops, a director of CorVel Corp (CRVL), reported insider transactions executed on 08/07/2025. He sold a total of 2,000 common shares (500 sold directly and 1,500 sold indirectly via an irrevocable trust) at $88.58 per share, leaving him with 24,192 shares held directly and 113,713 shares held indirectly, for a combined beneficial ownership of 137,905 shares.
He also received a non-qualified stock option covering 1,500 shares with an exercise price of $85.56, exercisable in four equal annual installments beginning 12 months after the grant and expiring on 08/07/2035. The filing documents the change in holdings and the option grant without additional explanatory detail.
Positive
- Maintained substantial ownership: Combined direct and indirect beneficial ownership totals 137,905 shares after the transactions.
- Option grant granted with standard vesting: Received 1,500 non-qualified stock options at an exercise price of $85.56, exercisable in four equal annual installments beginning 12 months after grant.
Negative
- Insider dispositions: Sold a total of 2,000 shares (500 direct, 1,500 indirect) at $88.58 per share on 08/07/2025.
Insights
TL;DR: Routine insider sale plus option grant; ownership remains substantial.
The Form 4 shows a director-level sale of 2,000 shares at $88.58 and a contemporaneous grant of 1,500 non-qualified stock options at an $85.56 exercise price. Post-transaction beneficial ownership totals 137,905 shares, indicating continued material ownership. The option vests in four equal annual installments starting 12 months after grant, with a 10-year expiration, consistent with standard executive incentive structures. No other compensatory or hedging arrangements are disclosed in this filing.
TL;DR: Disclosure is straightforward; option vesting schedule is typical for retention incentives.
The report documents both disposition and grant activity by a director and identifies indirect ownership via a named irrevocable trust. The exercisability in annual installments beginning one year after grant aligns with customary retention-focused awards. The sale activity is quantifiable (500 direct; 1,500 indirect) and the continued combined holding of 137,905 shares suggests ongoing alignment with shareholders. The filing contains no governance flags such as pledged shares or related-party conflicts beyond the trust designation.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Non-Qualified Stock Option (right to buy) | 1,500 | $0.00 | -- |
| Sale | Common Stock | 500 | $88.58 | $44K |
| Sale | Common Stock | 1,500 | $88.58 | $133K |
Footnotes (1)
- [object Object]